Phorbol ester binding and phorol ester-induced arachidonic acid metabolism in a highly responsive murine fibrosarcoma cell line and in a less-responsive variant by Batchev, Alexander C. et al.
CLIN. EXPL. METASTASIS, 1986, VOL. 4, NO. 1, 51--61 
Phorbol ester binding and phorol e s ter - induced  arachidonic  
ac id  metabo l i sm  in a h ighly  responsive  m u r i n e  f ibrosarcoma 
ce l l  l ine  and in a less -responsive  variant 
A L E X A N D E R  C. B A T C H E V ,  B R U C E  L.  R I S E R ,  
E R I N  G.  H E L L N E R ,  S U Z A N N E  E. G.  F L I G I E L  
and J A M E S  V A R A N I  
Department  of Pathology, University of Michigan Medical School, 
Ann Arbor,  Michigan 48109, U.S.A. 
(Received 13 October 1985; accepted 26 December 1985) 
Phorbol ester binding was examined in two lines of murine fibrosarcoma cells. 
The  two cell lines were isolated from the same parent tumor but respond 
differentially to stimulation with phorbol esters. In one of the lines, these agents 
stimulate a rapid attachment and spreading response and induce directional 
migration. The  other cell line does not migrate in response to stimulation with 
phorbol esters and the attachment and spreading response is slow. The cell line 
which responds actively to phorbol ester stimulation is highly malignant when 
injected into syngeneic animals while the other line is of low tumorigenicity and is 
virtually non-metastatic. In spite of these differences, both lines were found in the 
present study to bind [3H]4l~-phorbol-12/~, 13~-dibutyrate in a receptor- 
mediated fashion. The  characteristics of binding were virtually identical between 
the two cell lines. In additional studies, araehidonic acid metabolism was 
examined in the same two lines. In the highly responsive line, PMA stimulated a 
rapid release of [3H]arachidonic acid and its conversion into cyclooxygenase and 
lipoxygenase products. In the less-responsive line, PMA stimulated a slower 
release of [3H]arachidonic acid from prelabeled cells. The  quantity of arachidonic 
acid metabolites produced was also much less. These studies suggest that the 
disparity between the two cell lines in their response to phorbol ester stimulation 
is not the result of differences in the initial interaction between the cells and ligand 
but may result from alterations in their signal transductance mechanism. This 
may be the result of inherent differences in capacity for arachidonic acid 
metabolism. 
Introduct ion  
M a n y  d i f fe ren t  t ypes  of  m a l i g n a n t  t u m o r  cel ls  a re  capab le  of  c h e m o t a c t i c  
r e sponses  [23] and  the re  is ev idence  to sugges t  tha t  c h e m o t a c t i c  r e sponses  m a y  p lay  a 
role  in the  invas ion  and  me ta s t a t i c  p rocesses  [13, 16]. T h e  ce l lu la r  and  m o l e c u l a r  
bas is  of  the  c h e m o t a c t i c  r e sponse  in t u m o r  cells has not  been  ful ly  de l i nea t ed  b u t  
some  of  the  key  fea tures  are  b e g i n n i n g  to be  u n d e r s t o o d .  F a c t o r s  w h i c h  p r o d u c e  a 
s t i m u l a t i o n  of  m o t i l i t y  also i nduce  an increase  in c e l l - t o - s u b s t r a t e  adhes iveness  
[24, 25]. T h e s e  b io log ica l  events  are  p r e s u m e d  to resu l t  f r om the  b i n d i n g  o f  the  
s t i m u l a t i n g  l igand  to specif ic  ce l lu la r  r ecep to rs ,  a l t h o u g h  wi th  m o s t  t u m o r  cells,  
b i n d i n g  s tud ies  have  no t  been  ca r r i ed  out .  O n e  excep t ion  to th is  is the  W a l k e r  256 
c a r c i n o s a r c o m a  line.  T h e s e  cells have been  shown  to b i n d  the  c he mota c t i c a l l y  act ive 
p h o r b o l  es ters  and  c h e m o t a c t i c a l l y  act ive N - f o r m y l  p e p t i d e s  in a r e c e p t o r - m e d i a t e d  
m a n n e r  [6, 14, 17]. W i t h  r ega rds  to p h o r b o l  es ter  b i n d i n g ,  the  W a l k e r  cells  a p p e a r  to 
be s imi la r  to a n u m b e r  of  o t h e r  n o n m a l i g n a n t  cell  t ypes  wh ich  have  been  
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characterized [5, 7, 11,18, 19, 21]. T h e y  also appear  to be similar to leukocytes with 
regards to N- fo rm y l  peptide binding (in te rms of affinity and specificity) but  have 
many  fewer receptors than rabbit  or human  polymorphonuclear  granulocytes 
[1, 28]. 
T h e  present  s tudy was undertaken as part  of our  effort to delineate the biological 
basis of s t imulus-coupled responses in mal ignant  cells. In  this s tudy we compared  
two lines of murine  f ibrosarcoma cells (derived f rom the same parent  tumor)  for 
responsiveness to st imulation with phorbol  esters. In  one of the lines, st imulation led 
to a rapid cel l- to-substrate a t tachment  and spreading of the cells. Stimulation of 
these cells also resulted in enhanced motility. T h e  other cell line did not demonstrate  
increased motil i ty and cell a t tachment  and spreading was much  slower. In  spite of 
these differences in biological responsiveness, the binding of phorbol  esters by the 
two cell lines was virtually identical. In  fur ther  studies it was shown that  arachidonic 
acid was released f rom both  lines in response to phorbol  ester st imulation and 
metabolized into cyclooxygenase and lipoxygenase metabolites.  However ,  the more  
highly responsive cells released arachidonic acid more  rapidly and produced greater 
quantities of arachidonic acid metaboli tes than the less-responsive cells. These  
findings suggest that the disparity in biological activity between the two lines is not 
the result of differences in the initial interaction of the cells with the active ligand. 
There  may be differences, however, in the signal transduction mechanism between 
the cells and this may be related to differences in the inherent capacity of the cells for 
arachidonic acid metabolism. 
Materials  an d  m e t h o d s  
Cells 
T w o  murine  f ibrosarcoma cell lines, designated as 1.2 and 1.2/anti-B r respec- 
tively, were used in this study. T h e  two lines were established in our laboratory f rom 
a 3-methylcholanthrene- induced tumor  in a C57BL/6 mouse. The  isolation and 
characterization of these lines have been described in our previous report  [27]. T h e  
1.2 cell line is highly malignant  when injected into syngeneic mice. T h e  1.2/anti-B r 
cell line is a low-malignant  variant. For  the present  study, both  lines were 
maintained in monolayer  culture using R P M I - 1 6 4 0  med ium supplemented  with 10 
per cent fetal bovine serum, 100 U/m1 of penicillin, 100 #g/m1 of s t reptomycin and 
2-5 #g/ml  of fungizone as the culture medium.  T h e  cells were grown at 37°C in 5 per 
cent CO 2 and subcultured by trypsinization as required. Prior to use, both  cell lines 
were shown to be free of mycoplasma contamination.  
Reagents 
Unlabeled phorbol  and phorbol  esters were obtained f rom Sigma Chemical 
Company  (St Louis, Missouri).  These  included 4fl-phorbol (phorbol),  4fl-phorbol-  
12-myristate-13-acetate (PMA),  4fl-phorbol-12fl, 13~-dibutyrate (PDB), 4fl- 
phorbol-12,  13-dibenzoate (PDBz) and 4fl-phorbol-12, 13-diacetate (PDA). Upon  
arrival in the laboratory,  each of the agents was resuspended in dimethyl  sulfoxide at 
1 mg/ml ,  aliquoted into small vials and frozen at -- 20°C. Tr i t ia ted PDB ([aH]PDB) 
was obtained f rom New England Nuclear  (Boston, Massachusetts).  T h e  stock 
solution contained 12"2 Ci /mmol  in ethanol. 
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Cell spreading on plastic culture dishes 
Spreading of the cells on 35 m m  (diameter) plastic culture dishes was used as the 
indicator of biological activity. Although the phorbol  esters induce cell- to-substrate 
a t tachment  and moti l i ty [26] in addition to cell spreading, spreading proved to be the 
most  convenient  parameter  to quantify, particularly when a large n u m b e r  of  samples 
were to be analyzed at a single t ime point.  Each dish received 1-9 ml of R P M I - 1 6 4 0  
culture med ium  containing 10 per  cent fetal calf serum and the appropriate  amount  
of the various phorbol  analogues. T h e  cells (5"0 × 105 per dish) were then added and 
the dishes incubated at 37°C. At various t imes later, the non-adherent  cells were 
removed f rom control and treated dishes and counted with an electronic particle 
counter.  T h e  dishes were flooded with 2 per  cent glutaraldehyde and the number  of 
spread cells was determined using a microscope with a calibrated grid in the 
eyepiece. 
Binding assay 
T h e  ligand binding assays were carried out using the protocol described 
previously with the Walker 256 carcinosarcoma cells [6]. Th is  is a modification of the 
procedure  described by Sando et al. for peripheral  blood lymphocytes  [19]. The  cells 
were suspended in R P M  I-1640 m ed i um  supplemented  with 10 per  cent fetal bovine 
serum at 12 × 106 cells per  ml and 0-4 ml of cell suspension was aliquoted into 
12 × 75 m m  glass tubes. Following this, 0"1 ml of culture medium,  with the desired 
amount  of [3H]PDB and (in some cases) various amounts  of non-radioact ive phorbol  
or phorbol  esters, were added to the tubes. T h e  tubes were then incubated at 37°C 
and 5 per cent CO2. At the end of the incubation period (ranging f rom 2 to 120 min), 
the cells were collected on Wha t m an  filters and separated f rom the unbound  
radioactivity in a Mill ipore filtration manifold (Millipore Co., Bedford, Massa-  
chusetts). Fifty millilitres of phosphate-buffered saline at room tempera ture  was 
used to wash the cells f rom the reaction tubes onto the collection filters. T h e  filters 
containing the cells with the bound [3H]PDB were counted in glass vials containing 
aqueous scintillation fluid for 10 min. T h e  counting efficiency for the [3H]PDB was 
32 per cent. Non-specific binding of [3H]PDB to the cells was est imated f rom the 
binding in the presence of 3/tM unlabeled PMA.  Background counts were 
determined f rom incubations containing all of the reactants except the cells. 
Prel iminary studies indicated that ligand binding was linear with cell n u m b e r  at the 
concentrat ion of cells used. Binding data was analyzed by the Scatchard method [20] 
using the computer  program,  L I G A N D  [15]. 
Jlr achidonic acid metabolism 
[3H]Arachidonic acid (87 Ci/mmol) ,  obtained f rom New England Nuclear,  was 
used to measure  arachidonic acid release f rom the control and st imulated cells. 
Freshly harvested cells were labeled by preincubat ion for 2h  with l # C i  
[3H]arachidonic acid per 5 × 107 cells in 5 ml R P M I - 1 6 4 0  culture med ium supple-  
mented  with 10 per  cent fetal bovine serum. Incubat ion was carried out at 37°C and 
5 per  cent CO2. Dur ing  the labeling procedure,  the cells were kept in tubes and 
maintained in suspension by gentle shaking. T h e  distr ibution of the radioactivity 
within the labeled cells was determined by subjecting the labeled cells to a Folch 
extraction [9] and analyzing the chloroform-soluble  fraction by thin-layer chroma-  
tography using a modification of the solvent system described by Skipski et al. [22]. 
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Depending on the experiment, we were able to obtain 1-2 x 105 counts per minute 
(CPM) of [aH]arachidonic acid incorporated per 1 x 106 cells. Nearly all of the 
incorporated material was found in the chloroform-soluble phase and when this 
material was analyzed, the radioactivity was found in bands co-migrating with 
phosphatidylcholine, phosphatidylinositol, phosphatidylserine and phosphatidyl- 
ethanolamine. Less than 10 per cent of the chloroform-soluble radioactivity was in 
bands which co-migrated with free fatty acids, triglycerides and Cholesterol esters. 
After labeling, the cells were centrifuged and washed twice in culture medium to 
remove unincorporated [3H]arachidonic acid. The  cells were then put into tubes in 
aliquots, stimulated with PMA and incubated at 37°C and 5 per cent CO 2. At various 
times thereafter, 200#1 samples (2 x 106 cells) were removed from the tubes. The 
samples were added to 300 #l phosphate-buffered saline and the cells separated from 
the supernatant fluid by centrifugation. Radioactivity in the supernatant fluid was 
then determined using a fl-scintillation counter. 
Levels of prostaglandin E 2 (PGE2) and leukotriene C 4 (LTC4) were quantified in 
control and stimulated cells. For these assays, the cells were harvested, washed four 
times in serum-free culture medium and incubated at 5 × 106 cells per ml of serum- 
free medium. At various subsequent times, the supernatant fluids (for PGE2) or the 
cells and supernatant fluid (for TLC4)  were harvested, extracted and assayed. The 
extraction procedure involved precipitation of the protein with acetonitrile, and 
extraction of most neutral lipids from the acidified acetonitrile fraction with 
petroleum ether. After removal of the ether layer, the remaining aqueous phase was 
extracted twice with ethyl acetate and dried in air. The  residue was redissolved in 
phosphate-buffered saline containing 0"1 per cent gelatin and assayed for the 
metabolites using radioimmunoassay (RIA) procedures. Assays for PGE 2 were 
performed with antibodies and labeled ligand obtained from New England Nuclear. 
The  limit of sensitivity was 3"8 pg per tube. Cross reactivity of the antibody with 
related prostaglandins was low (less than 1"8 per cent). The L T C  4 assay was also 
carried out using a New England Nuclear assay kit. The limit of sensitivity for this 
assay was 3"7 pg per reaction tube. The  antibody to L T C  4 cross-reacted with L T D  4 
(55 per cent) and L T E  4 (8"6 per cent) but showed low cross-reactivity (less than 1 per 
cent) with LTB4, mono-hydroxyeicosatetraenoic acids (mono-HETEs)  and various 
prostaglandins. The actual assay procedures were carried out by the Ligand Core 
Laboratory at the Michigan Diabetes Research and Training Center (Ann Arbor, 
Michigan). 
R e s u l t s  
Biological response to phorbol esters 
Spreading of the cells on plastic culture dishes was used as an indicator of 
biological response to the phorbol esters. When PDB was used as the stimulating 
agent with the 1.2 cells, the cells rapidly attached to the plastic culture dishes and 
spread (figure 1). The  effects were seen as early as 15 min after treatment and were 
dose responsive. Activity was observed at concentrations as low as 2 nM and a half- 
maximal response was achieved at approximately 25nM. PDB also induced 
attachment and spreading in the 1.2/anti-B r cells. With these cells, the response 
occurred much more slowly than with the 1.2 cells. Significant cell spreading was not 
observed until 1 h after treatment and the maximum difference between the treated 
and control cells was not seen until much later (2 h or longer). 
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Time-course of PDB-induced spreading (a, b) and [3H]PDB binding (c, d) by the 
1.2 and 1.2/anti-B r cells. The  spreading response is shown in the upper panels: (a) 1.2 
cells and (b) 1.2/anti-B r cells. The  spreading assay was carried out as described in the 
Methods section. Each value is the average of duplicate samples+ the difference 
between the individual numbers and the averages in a single experiment. The  
experiment was carried out three times with very similar results (C), control; Q, 80 nM 
PDB). The  time-course at [3H]PDB is shown in the lower panels; (c) 1.2 cells and (d) 
1.2/anti-B c cells. The  binding assay was carried out as described in the Materials and 
methods section. Each value is the average of duplicate samples+the  difference 
between the individual numbers and the averages in a single experiment. The 
experiment was carried out three times with very similar results. 
O t h e r  p h o r b o l  es ters ,  in a d d i t i o n  to P D B ,  also s t i m u l a t e d  cell  s p r e a d i n g  o f  the  1.2 
and  1 .2 /an t i -B  r cells.  T h e s e  i nc lude  P M A ,  P D B z  and  P D A .  W i t h  each,  the  effects 
were  dose  re spons ive .  P M A  was the  m o s t  act ive l igand,  s t i m u l a t i n g  a h a l f - m a x i m a l  
r e sponse  in b o t h  cells at  5 - 1 0 n M .  P D B z  was i n t e r m e d i a t e  (25--35nM for hal f -  
m a x i m a l  r esponse)  and  P D A  was the  least  ac t ive  (750--900nM for h a l f - m a x i m a l  
response) .  I n t e r e s t i ng ly ,  p h o r b o l  i t se l f  also s h o w e d  ac t iv i ty  at  ve ry  h igh  con-  
cen t r a t i ons  (2 #M). W e  had  seen no  ac t iv i ty  wi th  th is  agen t  at concen t r a t i ons  up  to 
10#M in ou r  p r ev ious  s t u d y  wi th  the  W a l k e r  256 c a r c i n o s a r c o m a  cells  [6]. 
K ine t i ca l ly ,  the  r e sponse  i n d u c e d  b y  the  va r ious  P D B  ana logues  were  s imi la r  to the  
r e sponse  i n d u c e d  b y  P D B  i tse l f  (see f igure  1). T h a t  is, the  r e sponse  of  the  1.2 cells 
was ve ry  r a p i d  whi le  the  1 .2 /an t i -B  r cel ls  r e s p o n d e d  m u c h  m o r e  s lowly.  
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PDB-binding studies 
Because of the kinetic differences between the 1.2 and 1.2/anti-B r cells in their 
response to phorbol  ester stimulation, we examined phorbol  ester binding by the two 
lines. [3H]PDB was used for this. T h e  t ime-course of [3H]PDB binding to the 1.2 
and 1.2/anti-B r cells is shown in figure 1. With  both cell lines, binding was rapid. 
Peak binding was seen by 30 rain and there was a fall-off at later t ime periods. The  
fall-off in the amount  of bound [3H]PDB at the later t ime-points  is not unique to 
these cells. Similar findings have been made with other cell types [6, 7, 19, 21]. T h e  
t ime-course of ligand binding is in accord with the kinetics of the biological response 
induced in the 1.2 cells. In the 1.2/anti-B r cells, it appears that the delay in cell 
spreading is not due to slower ligand binding to these cells. Rather,  the ligand b i rds  
to these cells as rapidly as to the 1.2 cells. 
T h e  binding of [3H]PDB by both  cell lines was concentrat ion dependent  over the 
range of 9-270 nM and was saturable (not shown). At the highest concentrations 
used, over 90 per cent of the total binding was inhibited by excess (3 #M) PMA. 
When  the binding data was plotted by the Scatchard method and analyzed using a 
single-site model,  we estimated approximately  3-8--4-0 x 10 s binding sites per cell for 
both  cell types with Kds in the range of 40--50 riM. These  values are in accord with the 
concentrations of P D B  stimulating half-maximal  biological responses with the 1.2 
and 1.2/anti-B r cells. 
Binding of the [3H]PDB to both cell lines was also reversible. This  was 
demonstra ted  by adding 3 #M P M A  to the cells 15 rain after the cells had been 
incubated with [3H]PDB and then incubating them for an additional 15 min. The  
addition of the P M A  15 min after incubation with the [3H]PDB released 91 per cent 
of  the total radioactivity f rom the 1.2 cells and 84 per cent of the total radioactivity 
f rom the 1.2/anti-B r cells (not shown). Since it has already been demonstra ted that 
non-specific binding accounts for approximately  10 per  cent of the total binding, this 
indicates that nearly 100 per cent of the specific binding was reversible after 15 min. 
T h e  analogues of PDB which induced cell spreading were also examined for 
ability to interfere with [3H]PDB binding by the 1.2 and 1.2/anti-B r cells. All three 
analogues (i.e. PMA,  PDBz  and PDA)  competed with [3H]PDB. Inhibi t ion was 
dose responsive with all of the analogues and there was a close relationship between 
those concentrations which induced a biological response and those concentrations 
which inhibited [3H]PDB binding (not shown). 
-4rachidonic acid metabolism 
T h e  1.2 and 1.2/anti-B r cells were prelabeled with [3H]arachidonic acid as 
described in the Methods  section and incubated at 37°C. At various times later, 
control cells and cells st imulated with P M A  (16 riM) were examined for release of 
radioactivity into the culture fluid (figure 2). P M A  stimulated a rapid release of 
radioactivity f rom the 1.2 cells. Increased release (over baseline values) was seen as 
early as 5 rain after st imulation and peaked at 30 rain. At later times, the amount  of 
radioactivity recovered f rom the culture fluids was decreased. With  the 1.2/anti-B r 
cells, significant differences between the control and PMA-s t imula ted  cells were not 
observed at the earliest t ime points (5 and 15rain),  but  were seen by 30rain. In  
addition to these differences in the kinetics of release, differences in the total amount  
released were also observed. T h e  total amount  released was much  greater f rom the 
1.2 cells than f rom the 1.2/anti-B r cells (figure 2). I t  can also be seen f rom figure 2 that 
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Release of radioactivity from [3H]arachidonic acid pre-labeled 1.2 cells (a) and 
1.2/anti-B r cells (b). The cells were pre-treated with [3H]arachidonic acid as described 
in the Methods section and then incubated in control medium or medium containing 
16 nM PMA. The values shown are the amount of radioactivity recovered from the 
culture fluid at various subsequent times. Values are averages of duplicate tubes in a 
single experiment where the duplicate values were always within 15 per cent of the 
averages. The experiment was carried out seven times with very similar results. 
©, Unstimulated; O, 16 nM PMA. 
the spon taneous  release of radioact ivi ty  f rom the 1.2 cells was greater  than  f rom the 
1 .2/ant i -B r cells. These  resul ts  are s imi lar  to what  we have prev ious ly  repor ted  [8]. 
T h e  1.2 and  1 .2/ant i -B r cells were also examined  for the synthes is  of specific 
a rach idonic  acid metabol i tes .  Fo r  these exper iments ,  1;he cells were compared  at a 
s ingle t ime  po in t  (4 h after s t imula t ion) .  P M A  s t imula ted  the p r o d u c t i o n  of P G E  2 in 
bo th  cell l ines and  the ratios of the a m o u n t s  p roduced  in the s t imula ted  versus  
cont ro l  cells were very  s imi lar  (the table). As was seen wi th  the release of 
radioact ivi ty ,  however ,  the a m o u n t  of P G E  2 p roduced  in  the 1.2 cells was m u c h  
greater  u n d e r  bo th  cont ro l  and  s t imula ted  cond i t ions  t han  in  the 1 .2/ant i -B r cells. 
T P A  also s t imula ted  the p roduc t i on  of L T C  4 in the 1.2 cells b u t  we detected no 
P r o d u c t i o n  o f  P G E  2 a n d  L T C  4 b y  c o n t r o l  a n d  P M A - s t i m u l a t e d  1.2 a n d  1 .2 /ant i -B '  
c e l l s  ° . 
Amount produced 
(ng/5 x 106 cells/4 h) 
Cell line Stimulation PGE~ LTC~ 
1.2 None 10"8+ 1"1 0"2+0"1 
16 mw PMA 25"3 -+ 3"3 1 "0__+ 0"1 
1.2/anti-B r None 1"0 + 0"2 0"2_+ 0"1 
16nM PMA 2"5_+0"3 0'1 _+0"1 
a The cells were harvested from culture and incubated in control medium or medium 
containing 16 nM PMA for 4h. The culture fluids (without the cells for PGE 2 and with the 
cells for LTC4) were extracted and analyzed by radioimmunoassay as described in the 
Methods section. 
Values shown are averages + the difference between the individual values and the mean 
values in a single experiment. The experiment was run twice with similar results. 
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increased production in the 1.2/anti-B r cells. This may, however, reflect the fact that 
the assay lacks the sensitivity to detect small changes in absolute amounts of this 
metabolite. 
Using P G E  2 as the indicator metabolite, the kinetics of production was examined 
in control and PMA-st imulated 1.2 cells. Increased PGE2 synthesis was detected as 
early as 5 min after stimulation with 16 nM P M A  (figure 3), suggesting that the rapid 
release of arachidonic acid from pre-labeled cells was accompanied by increased 
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Figure 3. Time-course of PGE 2 production by the 1.2 cells. The cells were harvested from 
culture and incubated for varying periods of time in control medium and in medium 
stimulated with 16 nM PMA. At the appropriate times, the culture fluids were harvested 
and analyzed for PGE 2 as described in the Methods section. ©, Unstimulated; O, 
16 nM PMA. 
D i s c u s s i o n  
In the present study, we examined phorbol ester binding by two cell lines derived 
from a murine fibrosarcoma and phorbol ester-stimulated arachidonic acid metabol- 
ism in the same cells. These lines were examined because although they are derived 
from the same parent tumor,  they respond very differently to stimulation with 
phorbol esters. The  1.2 cells are chemotactically responsive [26] and rapidly attach 
and spread when stimulated with these agents [26 and this report]. The  1.2/anti-B r 
cells attach and spread much more slowly when stimulated and there is no 
demonstrable stimulation of motility [26 and this report]. In spite of these 
differences, the phorbol ester binding characteristics of the two cell lines were found 
in the present study to be very similar. The  kinetics of ligand binding and the 
apparent affinity of the receptor for the ligand were almost identical for the two cell 
lines. Likewise, the specificity of the receptor from the two lines also appeared to be 
indistinguishable based on competition studies using several different phorbol 
esters. Based on these observations, it is reasonable to suggest that the differences in 
biological activity between the two cell lines are not the result of differences in the 
initial interaction between the ligand and the cells. 
Although the two cell lines appeared to be indistinguishable in their initial 
interaction with the phorbol esters, there may be differences between the lines in how 
the signal generated by ligand binding is transduced. This may result from 
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quantitat ive or qualitative differences related to arachidonic acid metabolism. When  
the highly responsive 1.2 cells were st imulated with P M A  there was a rapid release of  
arachidonic acid f rom phosphol ipid pools and a rapid conversion into cyclooxy- 
genase and lipoxygenase metabolites.  With  the 1.2/anti-B r cells, the release of 
arachidonic acid f rom prelabeled cells occurred more  slowly. Perhaps more  
important ly,  the overall amount  of arachidonic acid released was much  less f rom the 
1.2/anti-B r cells and correspondingly smaller amounts  of  metaboli tes were formed.  
In  fact, we detected no increase in L T C 4  levels over  baseline values in the P M A -  
st imulated 1.2/anti-B r cells. Metaboli tes of arachidonic acid, in particular, l ipoxy- 
genase products ,  are known to serve as internal mediators  of s t imulus-coupled 
responses in other cells [10]. I t  may  be, therefore, that the ability of  the f ibrosarcoma 
cells to respond biologically to phorbol  esters is controlled, at least in part,  by the 
inherent  capacity of the cells to metabolize arachidonic acid and produce biologically 
important  mediators  f rom this essential fatty acid. 
T h e  identification of PMA-sensi t ive  and PMA-res is tant  variants f rom the same 
parent  line is not unique to the mur ine  f ibrosarcoma cells investigated here. Previous 
investigations have identified proliferative and non-proliferat ive variants of 3T3 
cells [3] and growth factor-producing and non-producing  variants of the E L ,  
l ymphoma  [18]. T h e  PMA-respons ive  and non-responsive variants of both cell lines 
bind phorbol  esters with indistinguishable characteristics. With  the 3T3 cells, ligand 
binding by both the responsive and non-responsive variants led to an equivalent 
st imulation of protein kinase C activity and comparable  early phosphorylat ion 
events [2]. I t  was also shown, that both  the proliferative and the non-proliferat ive 
variants produced arachidonic acid metaboli tes in response to phorbol  ester 
st imulation [4]. This  was of interest since at least one of the arachidonic acid 
metaboli tes produced,  i.e. prostaglandin F2, , is known to be a potent  mitogen for the 
3T3 cells [12]. Although these observations might  suggest substantial differences 
between the 3T3 cells and the murine  f ibrosarcoma cells under  investigation here, it 
should be noted that the proliferative variants of the 3T3 cells produced greater 
quantities of arachidonic acid metaboli tes in both the presence and absence of 
st imulation than did the non-responsive variants [4]. Thus ,  the mur ine  f ibrosarcoma 
cells and the 3T3 cells may  be comparable.  If, in fact, the capacity to metabolize 
arachidonic acid is necessary for subsequent  biological responses to phorbol  ester 
st imulation, then the question that needs to be addressed is how the binding of the 
phorbol  esters leads to the kinds of changes in arachidonic acid metabol ism that 
produce the biological response. While our studies with the murine  f ibrosarcoma 
cells are directed toward unders tanding those responses, i.e. adhesiveness and 
motility, which may contr ibute to the capacity for invasion and metastasis, this 
question is of significance in other areas of investigation as well. 
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